Develops an AI/ML platform for biotech partners to discover and validate disease models, drug targets, and screening or surrogate biomarkers using multi-omics data
Develops an AI/ML platform for biotech partners to discover and validate disease models, drug targets, and screening or surrogate biomarkers using multi-omics data. The company describes its approach as a quantum mechanics-based operating system for drug and biomarker development, supporting precision therapeutics.